• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对2012例原发性皮肤恶性黑色素瘤患者的生存情况进行多因素回归分析。

Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.

作者信息

Søndergaard K, Schou G

出版信息

Virchows Arch A Pathol Anat Histopathol. 1985;406(2):179-95. doi: 10.1007/BF00737084.

DOI:10.1007/BF00737084
PMID:3923697
Abstract

Cox's multivariate regression model for survival data was applied to 2,012 patients with primary cutaneous melanoma in order to evaluate the relative prognostic value of numerous clinical and histological variables and to establish their prognostically most efficient combination. The material was divided into 4 groups according to the size of resection margin of the primary lesion (less than 2.0 cm, 2.0 cm, 2.1-4.9 cm, and greater than or equal to 5.0 cm). Data were analysed separately in these 4 groups and equivalent results were obtained. The risk factors were clinical stage, site of tumour, tumour thickness, level of invasion, mitotic activity, ulceration, lymphocytic reaction, predominant type of invasive tumour cell and partial regression. When accounting for these factors, histological type, nuclear pleomorphism, nucleolar size, vascular invasion, pigmentation, verrucous growth pattern, and dermal elastosis were without prognostic influence. The effect of sex and age of patient was uncertain and both variables, therefore, were retained in the model. By using Cox's method it is possible to make a qualified estimate of the survival for the individual patient.

摘要

为了评估众多临床和组织学变量的相对预后价值,并确定其预后最有效的组合,将Cox生存数据多变量回归模型应用于2012例原发性皮肤黑色素瘤患者。根据原发性病变切除边缘的大小(小于2.0 cm、2.0 cm、2.1 - 4.9 cm和大于或等于5.0 cm)将材料分为4组。在这4组中分别分析数据,并获得了等效结果。危险因素包括临床分期、肿瘤部位、肿瘤厚度、浸润水平、有丝分裂活性、溃疡、淋巴细胞反应、侵袭性肿瘤细胞的主要类型和部分消退。在考虑这些因素时,组织学类型、核多形性、核仁大小、血管浸润、色素沉着、疣状生长模式和真皮弹性组织变性无预后影响。患者的性别和年龄的影响不确定,因此这两个变量均保留在模型中。通过使用Cox方法,可以对个体患者的生存情况进行合理估计。

相似文献

1
Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.对2012例原发性皮肤恶性黑色素瘤患者的生存情况进行多因素回归分析。
Virchows Arch A Pathol Anat Histopathol. 1985;406(2):179-95. doi: 10.1007/BF00737084.
2
Prognostic factors in primary cutaneous malignant melanoma.原发性皮肤恶性黑色素瘤的预后因素
Am J Dermatopathol. 1985;7 Suppl:1-4. doi: 10.1097/00000372-198501001-00004.
3
A Retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 8. The Relative prognostic value of various clinical and histological features evaluated by Cox's regression model.一项对669例临床I期原发性皮肤恶性黑色素瘤的回顾性组织学研究。8. 通过Cox回归模型评估各种临床和组织学特征的相对预后价值。
Acta Pathol Microbiol Immunol Scand A. 1982 Nov;90(6):449-54. doi: 10.1111/j.1699-0463.1982.tb00121_90a.x.
4
Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.1469例临床I期原发性皮肤恶性黑色素瘤患者生存的治疗及临床病理因素。多因素回归分析。
Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):249-58. doi: 10.1007/BF00707987.
5
Biopsy and optimal size of margins of resection of primary cutaneous malignant melanomas.原发性皮肤恶性黑色素瘤的活检及切除切缘的最佳大小
Am J Dermatopathol. 1985;7 Suppl:127-9. doi: 10.1097/00000372-198501001-00023.
6
Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.局限性侵袭性皮肤黑色素瘤的预后因素:有丝分裂率、血管侵犯和微小卫星灶的高价值
Melanoma Res. 2005 Jun;15(3):169-77. doi: 10.1097/00008390-200506000-00005.
7
A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.一项对669例临床I期原发性皮肤恶性黑色素瘤的回顾性组织学研究。3. 肿瘤相关淋巴细胞浸润与年龄、性别、肿瘤细胞类型、色素沉着、细胞异型性、有丝分裂计数、浸润深度、溃疡、肿瘤类型及预后之间的关系。
Acta Pathol Microbiol Scand A. 1978 Nov;86A(6):523-30.
8
Prognostic value of tumour thickness in cutaneous malignant melanoma.肿瘤厚度在皮肤恶性黑色素瘤中的预后价值。
J Clin Pathol. 1983 Jan;36(1):51-6. doi: 10.1136/jcp.36.1.51.
9
Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.恶性黑色素瘤患者生存的临床和组织病理学预测因素:瑞典一项基于人群的研究
J Natl Cancer Inst. 1994 May 18;86(10):761-9. doi: 10.1093/jnci/86.10.761.
10
A retrosepctive histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour.一项对669例临床I期原发性皮肤恶性黑色素瘤的回顾性组织学研究。6. 真皮日光性弹力组织变性与患者的性别、年龄和生存以及与肿瘤的部位、组织学类型和浸润深度的关系。
Acta Pathol Microbiol Scand A. 1979 Sep;87A(5):361-6.

引用本文的文献

1
Is It Time to Supersede the Diagnostic Term "Melanoma In Situ with Regression?" A Narrative Review.是时候取代“伴有消退的原位黑色素瘤”这一诊断术语了吗?一篇叙述性综述。
Dermatopathology (Basel). 2023 Mar 22;10(1):120-127. doi: 10.3390/dermatopathology10010018.
2
Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.RAS 突变和 P53 表达在皮肤鳞状细胞癌中的预后意义。
Genes (Basel). 2020 Jul 6;11(7):751. doi: 10.3390/genes11070751.
3
Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.

本文引用的文献

1
Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I.皮肤恶性黑色素瘤。关于起源、发展、病因、扩散、治疗及预后的研究。I
Br J Plast Surg. 1962 Jan;15:49-94. doi: 10.1016/s0007-1226(62)80011-3.
2
Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.足部恶性黑色素瘤。125例原发性皮肤恶性黑色素瘤的临床病理研究。
Acta Pathol Microbiol Scand A. 1980 Sep;88(5):275-83.
3
The intra-lesional variation of type, level of invasion, and tumour thickness of primary cutaneous malignant melanoma.
系统筛选趋化因子,以鉴定候选物,建立用于癌症免疫治疗的异位淋巴结结构模型。
Sci Rep. 2017 Nov 22;7(1):15996. doi: 10.1038/s41598-017-15924-2.
4
Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.组织病理学上无色素性和色素性黑色素瘤的临床病理特征及生存情况比较:一项基于人群的研究
JAMA Dermatol. 2014 Dec;150(12):1306-314. doi: 10.1001/jamadermatol.2014.1348.
5
Morphometric, DNA and PCNA in thin malignant melanomas.
Med Oncol Tumor Pharmacother. 1993;10(3):87-94. doi: 10.1007/BF02987774.
6
Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.1469例临床I期原发性皮肤恶性黑色素瘤患者生存的治疗及临床病理因素。多因素回归分析。
Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):249-58. doi: 10.1007/BF00707987.
7
Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.I期临床的原发性皮肤薄恶性黑色素瘤的部分回归。486例研究。
Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):241-7. doi: 10.1007/BF00707986.
8
Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.
Virchows Arch A Pathol Anat Histopathol. 1987;410(4):355-61. doi: 10.1007/BF00711292.
9
The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group.临床I期皮肤黑色素瘤的死亡风险与原发肿瘤厚度之间的关系:无风险分级依据。苏格兰黑色素瘤研究小组
Br J Cancer. 1991 Sep;64(3):598-602. doi: 10.1038/bjc.1991.357.
10
The significance of inflammation and regression in melanoma.
Virchows Arch A Pathol Anat Histopathol. 1992;420(2):113-5. doi: 10.1007/BF02358800.
原发性皮肤恶性黑色素瘤的类型、浸润深度和肿瘤厚度的瘤内变化。
Acta Pathol Microbiol Scand A. 1980 Sep;88(5):269-74. doi: 10.1111/j.1699-0463.1980.tb02496.x.
4
Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity?发生于哈钦森黑素雀斑的恶性黑色素瘤是一种独立的疾病实体吗?
Histopathology. 1980 May;4(3):235-42. doi: 10.1111/j.1365-2559.1980.tb02918.x.
5
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics.皮肤I期黑色素瘤:根据组织学特征评估预后
Cancer. 1981 Oct 1;48(7):1668-73. doi: 10.1002/1097-0142(19811001)48:7<1668::aid-cncr2820480732>3.0.co;2-9.
6
Clinical course of cutaneous malignant melanoma related to histopathological criteria of primary tumour.
Scand J Plast Reconstr Surg. 1980;14(3):229-34. doi: 10.3109/02844318009106715.
7
A Retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 8. The Relative prognostic value of various clinical and histological features evaluated by Cox's regression model.一项对669例临床I期原发性皮肤恶性黑色素瘤的回顾性组织学研究。8. 通过Cox回归模型评估各种临床和组织学特征的相对预后价值。
Acta Pathol Microbiol Immunol Scand A. 1982 Nov;90(6):449-54. doi: 10.1111/j.1699-0463.1982.tb00121_90a.x.
8
Malignant melanoma of the skin: prognostic factors derived from a multifactorial analysis of 239 cases.
Am J Dermatopathol. 1982 Oct;4(5):411-2.
9
Survival with malignant melanoma: a regression analysis of prognostic factors.
Cancer. 1982 Jun 1;49(11):2414-9. doi: 10.1002/1097-0142(19820601)49:11<2414::aid-cncr2820491132>3.0.co;2-v.
10
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.临床分期为Ⅰ期的中等厚度(1.51 - 3.39毫米)黑色素瘤患者的预后因素。肿瘤生长和转移的概念模型。
Ann Surg. 1982 Jan;195(1):35-43. doi: 10.1097/00000658-198201001-00006.